OpenAlex
PricingAboutJobs
Log inGet started
Work

Dapagliflozin monotherapy in drug‐naïve patients with diabetes: a randomized‐controlled trial of low‐dose range

HTML

Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2012.01659.x
Authors: C. J. Bailey, N. Iqbal, C. T'joen, J. F. List
Institutions: Aston University, Princeton University, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Belgium)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: dapagliflozin, type 2 diabetes, SGLT2 inhibitors, monotherapy, drug-naive patients, glycemic control, HbA1c reduction, fasting blood glucose, weight loss, newly diagnosed diabetes, adverse events, tolerability, rescue medication, insulin-independent glucose lowering, dose comparison, body weight
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2001991301
FWCI: 9.68
Cites: 19
Cited by: 190
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms